Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Business Wire
Banner Health Launches Online Scheduling for Consumers with Kyruus
October 3, 2019 -
MobiHealthNews
Cloud management tool for dental practices CareStack lands $28M
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Appointment of CEO Mark Rothera to The Alliance for Regenerative Medicine’s 2020 Board of Directors
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
PR Newswire
TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain
October 2, 2019 -
GlobeNewswire
Tempest Therapeutics Announces Multiple Presentations at Upcoming Sitc 34th Annual Meeting
October 2, 2019 -
Business Wire
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001
October 1, 2019 -
PR Newswire
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
October 1, 2019 -
Oxford Nanopore
Oxford Nanopore enters into a non-exclusive agreement with Caribou Biosciences for CRISPR-Cas9 enrichment for nanopore sequencing
September 30, 2019 -
GlobeNewswire
Menlo Therapeutics Announces Completion of Enrollment of 233 Patients in Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
September 30, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)
September 30, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress
September 30, 2019 -
Business Standard
Eywa aims to make mark in US market with own label, skip generic trend
September 28, 2019 -
GlobeNewswire
Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020
September 26, 2019 -
Newswire
Artemis Health Wins 2019 SaaS Award From Appealie
September 26, 2019 -
GlobeNewswire
Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer
September 23, 2019 -
Business Wire
Nebula Genomics Launches Anonymous Genetic Testing
September 19, 2019 -
PR Newswire
Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO
September 19, 2019 -
PR Newswire
Benchling Launches New Products for Research Institutions and Biotech Startups to Accelerate Life Science Innovation
September 17, 2019 -
genomeweb
LunaPBC Partners With Medfusion to Integrate EHR, Genomic Data-Sharing Platform
September 17, 2019 -
PR Newswire
Firefly Health Closes $10.2 Million Series A Funding Round to Expand New Primary Care and Patient Experience Platform
September 16, 2019 -
GlobeNewswire
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy
September 16, 2019 -
Business Wire
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board
September 16, 2019 -
Business Wire
Devoted Health and Publix Team Up to Improve Flu Vaccination Coverage in Florida
September 12, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
September 10, 2019 -
BioSpectrum
Insilico Medicine secures $37M in series B funding
September 10, 2019 -
PR Web
CareStack and ClearGage Announce Technology Integration
September 10, 2019 -
GlobeNewswire
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
September 9, 2019 -
GlobeNewswire
United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4
September 9, 2019 -
Fierce Biotech
Insilico’s AI networks generate custom lead compounds for fibrosis in less than 50 days
September 4, 2019 -
GlobeNewswire
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
September 4, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
September 4, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)
September 4, 2019 -
Business Wire
Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer
September 4, 2019 -
Business Wire
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Additional Coordinated Care in Arizona, Georgia and Texas
September 4, 2019 -
Fierce Biotech
Biotech Vertex plunks down $950M for stem cell player Semma Therapeutics
September 3, 2019 -
GlobeNewswire
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
September 3, 2019 -
GlobeNewswire
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
August 27, 2019 -
PR Newswire
Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare
August 26, 2019 -
Fierce Biotech
Zogenix pays $250M upfront for startup Modis and its FDA ‘breakthrough’ med
August 26, 2019 -
Endpoint News
Modis Therapeutics -$30M launch round to $400M buyout deal — with $250M upfront — in 10 short months
August 26, 2019 -
PR Newswire
Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors
August 22, 2019 -
PR Newswire
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
August 21, 2019 -
Newswire
Healthcare Embracing New Era of Compliance and Analytics
August 20, 2019 -
STAT
Can targeting one protein complex solve multiple diseases? NodThera is betting on it
August 16, 2019 -
PR Newswire
Vitalware Named to the 2019 Inc. 5000 Fastest Growing Private Companies List for Fifth Consecutive Year
August 15, 2019 -
GlobeNewswire
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
August 14, 2019 -
PR Newswire
Iora Health Hires New Chief Operating Officer, Suzanne Hansen
August 13, 2019 -
Business Wire
Kyruus ProviderMatch® Patient Access Platform Now Powering Patient-Provider Matching at Norton Healthcare
August 6, 2019 -
PR Newswire
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
August 5, 2019 -
GlobeNewswire
Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders
August 1, 2019 -
PR Newswire
Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome
July 29, 2019 -
GlobeNewswire
Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS
July 25, 2019 -
PR Newswire
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
July 24, 2019 -
PR Newswire
Benchling Raises $34.5M Series C To Fuel Life Sciences R&D
July 24, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer
July 22, 2019 -
GlobeNewswire
Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center
July 22, 2019 -
Business Standard
Caplin Steriles gets USFDA approval for Tranexamic Acid Injection
July 18, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies
July 18, 2019 -
PR Newswire
TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform
July 18, 2019 -
GlobeNewswire
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States
July 18, 2019 -
GlobeNewswire
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
July 18, 2019 -
PR Newswire
Protenus Named 2019 Top Patient Privacy Solution by Black Book Market Research
July 11, 2019 -
PR Newswire
Embark Unleashes New, Best In Class Canine DNA Breed Identification Kit
July 9, 2019 -
GlobeNewswire
Pulmocide announces Scientific Reports (Nature Research) publication showing PC945 in combination with standard antifungal treatment causes a synergistic effect against Aspergillus fumigatus
July 2, 2019 -
PR Newswire
LunaPBC Named 2019 World Economic Forum Technology Pioneer
July 1, 2019 -
Business Wire
Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes
July 1, 2019 -
Nasdaq
Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab
June 27, 2019 -
PR Newswire
Novaerus Joins Clean Hospitals
June 20, 2019 -
Zacks Equity Research
Ultragenyx & Arcturus Therapeutics Expand Existing Agreement
June 20, 2019 -
Business Wire
Kyruus and Brandify Form Partnership to Help Health Systems Boost Brand Visibility and Patient Acquisition Online
June 18, 2019 -
Business Wire
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471
June 17, 2019 -
PR Newswire
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
June 17, 2019 -
Business Wire
Signaling Industry-Wide Shift to Integrated Mental Health, Quartet Announces Capital Raise and Strategic Partnership with Leading Medicaid Provider
June 13, 2019 -
GlobeNewswire
Unum Therapeutics Strengthens and Expands Leadership Team
June 13, 2019 -
PR Newswire
Akrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer
June 12, 2019 -
GlobeNewswire
Precision BioSciences Appoints Dario Scimeca as General Counsel
June 12, 2019 -
MobiHealthNews
Nebula Genomics, Merck KGaA’s EMD Serono partner on lung cancer pilot
June 11, 2019 -
Business Wire
Ivenix Infusion System Receives FDA 510(k) Clearance; Poised to Revolutionize the Infusion Pump Industry
June 11, 2019 -
GlobeNewswire
Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs
June 11, 2019 -
Business Wire
Darby Dental Supply Announces Partnership with CareStack®, Further Expanding Suite of Technology Solutions
June 5, 2019 -
Business Insider
Hua Medicine – Business & Pipeline Update
June 4, 2019 -
Business Wire
Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies
May 31, 2019 -
PR Newswire
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer
May 30, 2019 -
BioSpace
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award
May 29, 2019 -
PR Newswire
Former Advertising.com and AOL Executive Joins Protenus Team
May 22, 2019 -
PR Newswire
Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer
May 22, 2019 -
PR Newswire
Protenus Named a 2019 ‘Cool Vendor’ in Healthcare Artificial Intelligence by Gartner
May 20, 2019 -
PR Newswire
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
May 20, 2019
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.